Respiratory infections: a current and future threat

Respirology. 2009 Jul;14(5):651-5. doi: 10.1111/j.1440-1843.2009.01554.x.

Abstract

Despite all the medical progress in the last 50 years pulmonary infections continue to exact and extremely high human and economic cost. This review will focus on the human, pathogen and environmental factors that contribute to the continued global burden or respiratory diseases with a particular focus on areas where we might hope to see some progress in the coming decades.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / economics
  • Anti-Bacterial Agents / therapeutic use
  • Antiviral Agents / economics
  • Antiviral Agents / therapeutic use
  • Cost of Illness
  • Health Care Costs
  • Humans
  • Prevalence
  • Respiratory Tract Infections / drug therapy
  • Respiratory Tract Infections / epidemiology*
  • Respiratory Tract Infections / etiology*

Substances

  • Anti-Bacterial Agents
  • Antiviral Agents